Update on Leprosy in Immigrants in the United States: Status in the Year 2000
Open Access
- 15 March 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (6) , 930-937
- https://doi.org/10.1086/319357
Abstract
The World Health Organization established a goal in 1991 of “elimination of leprosy as a public health problem by the year 2000.” Although prevalence rates of leprosy have decreased in many geographic areas, it is clear that in some countries where leprosy is endemic, such as Brazil and India, this goal will not be reached. Leprosy is rare in the United States, but 85% of detected cases are in immigrants in whom the disease may mimic many common dermatologic and neurological entities, leading to delay of diagnosis. The statuses of polymerase chain reaction analysis, serological testing, and vaccines are reviewed. Effective multidrug therapy and prevention of permanent damage to nerves by early recognition and treatment will help prevent residual disabilities. This update reviews what is known about the pathophysiology and treatment of leprosy. Increased awareness will lead to earlier recognition, diagnosis, and treatment.Keywords
This publication has 12 references indexed in Scilit:
- Polymerase Chain Reaction Assay for the Detection and Identification ofMycobacterium lepraein Patients in the United StatesAmerican Journal of Clinical Pathology, 1998
- The management of leprosy reversal reactionsLeprosy Review, 1998
- Susceptibility to Leprosy Is Linked to the HumanNRAMP1GeneThe Journal of Infectious Diseases, 1998
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996
- Autoantibodies in leprosy seraClinical Rheumatology, 1996
- A study on performance of two serological assays for diagnosis of leprosy patientsLeprosy Review, 1995
- Imported leprosy in the United States, 1978 through 1988: an epidemic without secondary transmission.American Journal of Public Health, 1992
- Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.The Journal of Experimental Medicine, 1992
- Environmental Nonhuman Sources of LeprosyClinical Infectious Diseases, 1987
- THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICEThe Journal of Experimental Medicine, 1960